Scientists aren't concerned about new coronavirus variant eluding current vaccines

The identification of a potentially more transmissible coronavirus variant, primarily in the United Kingdom, has scientists and government officials, alike, sounding the alarm. The U.K. has tightened lockdown measures, and several continental European countries are halting flights to Great Britain. There's no evidence the variant affects the severity of COVID-19 infections, but increased infectiousness would make curbing the spread even harder, which is why certain areas of the U.K. may face restrictions until there's widespread vaccine availability. But could mutations like the one in the U.K. render those vaccines ineffective?
The consensus answer is reassuring for the time being. Daniel Altman, a professor of immunology at Imperial College London, told The Finanical Times the new variant should actually strengthen the case "for all to get vaccinated as soon as possible," explaining that the mutations won't be able to fool the neutralizing antibodies produced by the shot. Francois Balloux, director of the University College London Genetics Institute, concurred, saying "it's not a strain that should be able to escape protection provided by immunization from the current vaccines or prior infection."
That said, Trevor Bedford, a virologist who has kept a close watch on the virus throughout the pandemic, does think there should eventually be a process in place to update the vaccines so they can keep up with more significant mutations, much like there is for the flu vaccine. He is not, however, worried about that affecting the 2021 vaccine rollout, while also clarifying that potential future drops in vaccine efficacy will likely be "modest." Read more at The Financial Times and check out Bedford's Twitter thread below. Tim O'Donnell
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.
-
There is a 'third state' between life and death
Under the radar Cells can develop new abilities after their source organism dies
By Devika Rao, The Week US Published
-
Is it worth getting an interest-only mortgage?
The Explainer Your monthly payments may be cheaper but the full mortgage amount will need to be paid back eventually
By Marc Shoffman, The Week UK Published
-
Crossword: March 6, 2025
The Week's daily crossword
By The Week Staff Published
-
Texas outbreak brings 1st US measles death since 2015
Speed read The outbreak is concentrated in a 'close-knit, undervaccinated' Mennonite community in rural Gaines County
By Rafi Schwartz, The Week US Published
-
Mystery illness spreading in Congo rapidly kills dozens
Speed Read The World Health Organization said 53 people have died in an outbreak that originated in a village where three children ate a bat carcass
By Peter Weber, The Week US Published
-
Ozempic can curb alcohol cravings, study finds
Speed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
By Peter Weber, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
Microplastics accumulating in human brains, study finds
Speed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
By Peter Weber, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published
-
California declares bird flu emergency
Speed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized
By Rafi Schwartz, The Week US Published